Other News To Note
Friday, December 16, 2011
Dicerna Pharmaceuticals Inc., of Watertown, Mass., said partner Kyowa Hakko Kirin Co. Ltd., of Tokyo, elected to advance the first collaborative oncology candidate from research stage into formal development studies, triggering a $5 million milestone payment. In addition, Kyowa exercised an option to bring a second cancer target into the collaboration.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.